Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary indicates strong financial performance, strategic growth through M&A, and robust market positioning in aerospace and defense. Positive factors include a 17% organic growth, resilient supply chain, expanding margins, and high free cash flow conversion. The Q&A section highlights confidence in capacity management and backlog security, with no seasonality concerns. While management was vague on some specifics, overall sentiment is positive, driven by strong financial metrics and optimistic guidance.
Sales $459 million, representing 21% growth year-over-year. This consisted of 17% organic growth and 4% contribution from acquisitions (Olden Steels and Micro-Tronics). Growth was broad-based with all three key end markets delivering double-digit revenue growth.
Adjusted EBITDA $175 million, up 31% year-over-year. Adjusted EBITDA margins expanded 290 basis points year-over-year to 38.2%. Margin expansion was driven by operational efficiencies, cost optimization initiatives, and pricing strategies.
Free Cash Flow $25 million, up 107% year-over-year. Factors impacting cash flow included higher accounts receivable and inventory levels ($29 million), timing-related items ($50 million), and annual bonus payments ($20 million).
Net Leverage Declined from 4.2x to 4x TTM EBITDA during the quarter, and further to 2x post-IPO due to $1.2 billion in net proceeds from the IPO, of which $946 million was used to repay debt. This reduced annual cash interest expense by more than $70 million compared to 2025.
Proprietary Components: Arxis designs and builds proprietary components such as bearings, capacitors, connectors, and seals for harsh environments. These components are vital for advanced defense, aerospace, and industrial technology platforms.
New Business Wins: The company systematically tracks opportunities across its portfolio, drives cross-selling between business units, and aligns compensation to growth generation, fostering a proactive commercial culture.
End Market Growth: Arxis experienced double-digit growth across its three key end markets: Defense & Space, Commercial Aerospace, and Industrial Technology. Defense & Space benefited from alignment with government spending priorities, Commercial Aerospace saw growth from ramping production rates, and Industrial Technology experienced momentum in medical technology and semiconductor applications.
Geographic and Customer Diversification: Arxis is diversified across 40,000 part numbers, 600 platforms, and over 5,000 customers, providing a stable foundation for the business.
Operational Efficiencies: Adjusted EBITDA margins expanded by 290 basis points year-over-year to 38.2%, driven by cost optimization initiatives and operational efficiencies, particularly within the MCS segment.
Free Cash Flow: Free cash flow for Q1 was $25 million, up 107% year-over-year, despite timing-related impacts on cash flow.
M&A Strategy: Arxis completed the acquisition of Micro-Tronics in January and continues to leverage its partnership with Arcline for sourcing and executing acquisitions. The company operates in a fragmented market and has a repeatable process for integrating and scaling acquisitions.
IPO and Debt Reduction: The IPO generated $1.2 billion in net proceeds, with $946 million used to repay debt, reducing net leverage from 4x to 2x TTM EBITDA. This strengthens the balance sheet and enhances financial flexibility.
Free Cash Flow Challenges: Free cash flow for Q1 was seasonally lower and impacted by several timing-related items, including $17 million related to customer billing timing on defense programs, $13 million from additional months of cash interest payments ahead of IPO debt paydown, and $20 million related to annual bonus payments. These factors may continue to affect cash flow into Q2.
Debt and Leverage: Despite significant debt repayment post-IPO, the company had a net leverage of 4x at the end of Q1, which was reduced to 2x after the IPO. However, managing leverage and interest expense remains a critical focus area.
Supply Chain and Inventory Management: Record operating performance drove higher accounts receivable and inventory levels of approximately $29 million in Q1, which could pose challenges in managing working capital efficiently.
Defense Program Billing Timing: Customer billing timing on larger defense programs led to an increase in net contract assets, impacting cash flow by $17 million in Q1. This issue may persist into Q2.
Interest Expense: Although annual cash interest expense is expected to decline by more than $70 million post-IPO, it remains a significant cost factor that could impact financial flexibility.
Revenue Growth: Arxis expects total revenue for fiscal year 2026 to be in the range of $1.86 billion to $1.88 billion, representing 18% year-over-year growth, including 15% organic growth.
Adjusted EBITDA: The company projects adjusted EBITDA between $720 million and $730 million for fiscal year 2026, with an adjusted EBITDA margin of 38.8% at the midpoint.
End Market Growth: Arxis anticipates mid-teens organic growth across all three key end markets (Defense & Space, Commercial Aerospace, and Industrial Technology), driven by underlying industry volumes, new business growth, and price realization.
Capital Expenditures: Total CapEx is expected to be approximately $63 million, around 3% of revenue for fiscal year 2026.
Interest Expense: Following debt repayment post-IPO, annual cash interest expense is expected to decline to approximately $135 million for fiscal year 2026.
Tax Rate: The effective tax rate is projected to be around 25% for fiscal year 2026.
Depreciation and Amortization: Total annual depreciation and amortization is expected to be approximately $206 million.
Share-Based Compensation: Total share-based compensation expense is projected to be approximately $155 million, with expectations to normalize over the next few years.
The selected topic was not discussed during the call.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.